16-220
Showing 1 - 25 of 7,788
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
-
Los Angeles, California
- +10 more
Mar 24, 2022
Bullous Pemphigoid Trial in Worldwide (biological, other, drug)
Recruiting
- Bullous Pemphigoid
- efgartigimod PH20 SC
- +2 more
-
Fountain Valley, California
- +24 more
Jul 27, 2022
Asthma Trial in Chengdu (CM326, Placebo)
Recruiting
- Asthma
- CM326
- Placebo
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 21, 2022
Coronary Artery Disease, Chronic Heart Failure Trial in Moscow (Enhanced external counterpulsation)
Active, not recruiting
- Coronary Artery Disease
- Chronic Heart Failure
- Enhanced external counterpulsation
-
Moscow, Russian FederationI.M. Sechenov First Moscow State Medical University (Sechenov Un
Jun 13, 2023
Lupus Erythematosus, Systemic Trial in Worldwide (CC-220, Placebo)
Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)
Completed
- Atopic Dermatitis
- Abrocitinib 200 mg
- Dupilumab 300 mg
-
Birmingham, Alabama
- +150 more
Jun 9, 2022
Transgender Persons, Sexual Health Trial in Taipei (questionnaire, interview)
Recruiting
- Transgender Persons
- Sexual Health
- questionnaire, interview
-
Taipei, TaiwanSchool of Nursing of National Taiwan University
Jan 25, 2022
Lymphedema Surveillance Study
Active, not recruiting
- Breast Cancer
- Lymphedema
- Bilateral arm measurements
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 5, 2022
Chronic Exertional Compartment Syndrome Trial (Botulinum toxin A, Normal saline)
Not yet recruiting
- Chronic Exertional Compartment Syndrome
- Botulinum toxin A
- Normal saline
- (no location specified)
Feb 28, 2023
Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papillomavirus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023
220 Patients With Proximal Femur Fracture
Terminated
- Thromboembolism
-
Kongsberg, NorwayKongsberg Hospital, Vestre Viken Hospital Trust
Apr 14, 2021
Large Hiatal Hernia Trial in France (Laparoscopic hiatal hernia repair)
Not yet recruiting
- Large Hiatal Hernia
- Laparoscopic hiatal hernia repair
-
Bayonne, France
- +25 more
May 16, 2023
Bone Metastasis, Cancer Pain Trial in Worldwide (Tanezumab)
Completed
- Bone Metastasis
- Cancer Pain
-
Rosario, Santa FE, Argentina
- +88 more
Dec 21, 2022
Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)
Terminated
- Advanced BRAFV600 Wild-type Melanoma
- Cobimetinib
- +2 more
-
Tucson, Arizona
- +120 more
Aug 24, 2022
Same Morning vs Previous Evening Dosing Regimen for Assessment
Completed
- Bowel Preparation
-
Beijing, Beijing, China
- +1 more
Aug 14, 2023
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)
Refractory and/or Unexplained Chronic Cough Trial in Worldwide (BAY1817080, Placebo)
Completed
- Refractory and/or Unexplained Chronic Cough
- BAY1817080
- Placebo
-
Los Angeles, California
- +98 more
Jul 24, 2022
Epilepsy Trial in Toulouse (DIXI Medical Microdeep® Micro- Macro Depth electrodes, Standard electrodes)
Not yet recruiting
- Epilepsy
- DIXI Medical Microdeep® Micro- Macro Depth electrodes
- Standard electrodes
-
Toulouse, FranceUniversity Hospital of Toulouse
Oct 30, 2023